Welcure Drugs & Pharmaceuticals (WELCURE) Shareholding Pattern

NSE: WELCURE • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 0.00%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 94.41%
Total Shareholders 87,288
As of Dec 2025
View the latest shareholding pattern of Welcure Drugs & Pharmaceuticals (WELCURE) including promoter, FII, DII, and public holdings. Track WELCURE ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See WELCURE income statement)

Welcure Drugs & Pharmaceuticals (WELCURE) Shareholding Summary

  • Promoter holding remains unchanged at 0.00% in Dec 2025
  • FII/FPI holding remains unchanged at 0.00% in Dec 2025
  • DII holding remains unchanged at 0.00% in Dec 2025
  • Public holding has increased from 91.83% to 94.41% in Dec 2025
  • Number of shareholders increased from 76,954 to 87,288 in Dec 2025

WELCURE Quarterly Ownership Changes

Quarter-over-quarter changes for Welcure Drugs & Pharmaceuticals from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
No Change
DII Holding Change
Sept 2025 to Dec 2025
No Change
Public Holding Change
Sept 2025 to Dec 2025
+2.58%

Welcure Drugs & Pharmaceuticals (WELCURE) Quarterly Shareholding Trends

Visual breakdown of WELCURE ownership distribution over time. Learn more about Welcure Drugs & Pharmaceutical yearly highs lows.

Promoter
FII
DII
Public
Government

Rising institutional holdings in WELCURE often correlate with improved fundamentals. Check out WELCURE market capitalization.

Welcure Drugs & Pharmaceuticals (WELCURE) Shareholding Data

Download complete WELCURE ownership data for offline analysis. Discover WELCURE dividend track record.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 0.00% 0.00% 0.00% 0.00% 94.41% 5.59% 100.00% 87,288
Sept 2025 0.00% 0.00% 0.00% 0.00% 91.83% 8.17% 100.00% 76,954
Jun 2025 0.00% 0.00% 0.00% 0.00% 98.74% 1.26% 100.00% 37,298
Mar 2025 0.00% 0.00% 0.00% 0.00% 98.99% 1.01% 100.00% 32,366
Dec 2024 0.00% 0.00% 0.00% 0.00% 98.79% 1.21% 100.00% 30,605
Sept 2024 0.00% 0.00% 0.00% 0.00% 93.55% 6.45% 100.00% 30,218
Jun 2024 0.00% 0.00% 0.00% 0.00% 93.14% 6.86% 100.00% 31,045
Mar 2024 0.00% 0.00% 0.00% 0.00% 93.69% 6.31% 100.00% 31,530
Dec 2023 0.00% 0.00% 0.00% 0.00% 93.87% 6.13% 100.00% 29,957
Sept 2023 0.00% 0.00% 0.00% 0.00% 94.28% 5.72% 100.00% 29,593
Jun 2023 0.00% 0.00% 0.00% 0.00% 93.68% 6.32% 100.00% 29,251
Mar 2023 0.00% 0.00% 0.01% 0.00% 93.64% 6.34% 99.99% 29,013
Dec 2022 0.00% 0.00% 0.01% 0.00% 93.73% 6.26% 100.00% 29,075
Sept 2022 0.00% 0.00% 0.01% 0.00% 88.34% 11.65% 100.00% 24,699
Jun 2022 14.12% 0.00% 0.01% 0.00% 76.91% 8.95% 99.99% 20,463
Mar 2022 14.12% 0.00% 0.01% 0.00% 76.04% 9.82% 99.99% 18,951
Dec 2021 14.12% 0.00% 0.01% 0.00% 76.27% 9.59% 99.99% 18,909
Sept 2021 14.12% 0.00% 0.01% 0.00% 75.07% 10.80% 100.00% 17,380
Jun 2021 14.12% 0.00% 0.01% 0.00% 73.81% 12.05% 99.99% 16,524
Mar 2021 14.12% 0.00% 0.01% 0.00% 73.82% 12.04% 99.99% 16,542

WELCURE promoter holding above 50% indicates strong insider confidence. Explore the Welcure Drugs & Pharmaceutical value estimation for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 0.00% 0.00% 0.00% 0.00% 94.41% 5.59% 100.00% 87,288
Sept 2025 0.00% 0.00% 0.00% 0.00% 91.83% 8.17% 100.00% 76,954
Jun 2025 0.00% 0.00% 0.00% 0.00% 98.74% 1.26% 100.00% 37,298
Mar 2025 0.00% 0.00% 0.00% 0.00% 98.99% 1.01% 100.00% 32,366
Dec 2024 0.00% 0.00% 0.00% 0.00% 98.79% 1.21% 100.00% 30,605
Sept 2024 0.00% 0.00% 0.00% 0.00% 93.55% 6.45% 100.00% 30,218
Jun 2024 0.00% 0.00% 0.00% 0.00% 93.14% 6.86% 100.00% 31,045
Mar 2024 0.00% 0.00% 0.00% 0.00% 93.69% 6.31% 100.00% 31,530
Dec 2023 0.00% 0.00% 0.00% 0.00% 93.87% 6.13% 100.00% 29,957
Sept 2023 0.00% 0.00% 0.00% 0.00% 94.28% 5.72% 100.00% 29,593
Jun 2023 0.00% 0.00% 0.00% 0.00% 93.68% 6.32% 100.00% 29,251
Mar 2023 0.00% 0.00% 0.01% 0.00% 93.64% 6.34% 99.99% 29,013

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 0.00% 0.00% 0.00% 0.00% 94.41% 5.59% 100.00% 87,288
Dec 2024 0.00% 0.00% 0.00% 0.00% 98.79% 1.21% 100.00% 30,605
Dec 2023 0.00% 0.00% 0.00% 0.00% 93.87% 6.13% 100.00% 29,957
Dec 2022 0.00% 0.00% 0.01% 0.00% 93.73% 6.26% 100.00% 29,075
Dec 2021 14.12% 0.00% 0.01% 0.00% 76.27% 9.59% 99.99% 18,909

Year-over-year trends reveal long-term ownership shifts.

Understanding Welcure Drugs & Pharmaceuticals (WELCURE) Shareholding Pattern

Welcure Drugs & Pharmaceuticals shareholding pattern reveals who owns WELCURE stock and how ownership changes over time. High promoter stakes in WELCURE often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your WELCURE trades. WELCURE P/E comparison

Combine WELCURE ownership analysis with price movements and financial performance for a complete investment picture. (See WELCURE price to book ratio)